ArticleMolecular pharmaceutics2020

Site-Specific, Stoichiometric-Controlled, PEGylated Conjugates of Fibroblast Growth Factor 2 (FGF2) with Hydrophilic Auristatin Y for Highly Selective Killing of Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1 (FGFR1).

Mateusz Adam Krzyscik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.